Potential effects and adverse reactions vary between individuals.
Dragon Pharma RAD 140 10 mg is a selective androgen receptor modulator (SARM) also known as Testolone. This investigational compound is designed to bind selectively to androgen receptors in muscle and bone tissue, making it a subject of research for its potential to promote lean muscle growth, strength enhancement, and bone health with reduced androgenic side effects compared to traditional anabolic compounds.
Each package contains 100 tablets at 10 mg per tablet, supplied in a manufacturer sachet. RAD 140 has been investigated in preclinical research for its tissue-selective anabolic properties and its potential applications in muscle-wasting conditions and performance research. For related research compounds, explore our SARMs category and specifically LGD 4033 for comparative SARM research applications.
RAD 140 is one of the most potent and tissue-selective SARMs developed to date. Its unique structure allows for targeted androgen receptor activation in muscle and bone while minimizing activity in other tissues such as the prostate and seminal vesicles. This selectivity makes it a valuable compound for investigating the therapeutic potential of tissue-specific androgen receptor modulation.
Researchers value RAD 140 for its favorable pharmacokinetic profile, including oral bioavailability and a relatively long half-life. Its potent anabolic effects in preclinical models have made it a focus of research into muscle preservation, strength enhancement, and bone health. For investigators exploring other performance-related compounds, Anavar 10 offers complementary research avenues in anabolic and strength studies.
Current scientific literature on SARMs, including RAD 140, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.
RAD 140 10 mg is intended for research use only and is not approved for human consumption. Proper handling, dosing, and experimental protocols are essential for reliable results. For studies on metabolic enhancement, MK 2866 provides additional research avenues in selective androgen receptor modulation.
For research and laboratory use only. Dragon Pharma RAD 140 10 mg is a selective androgen receptor modulator. Proper handling, dosing, and experimental design are essential for obtaining reliable data.
Due to its favorable oral bioavailability and long half-life, RAD 140 is typically administered once daily in research settings. Consistent dosing schedules help maintain stable compound levels for reliable experimental results.
In research settings, RAD 140 dosing protocols vary widely depending on the experimental design, animal model, and specific research objectives.
Research note: RAD 140 is one of the most potent tissue-selective SARMs developed to date. Its ability to activate androgen receptors in muscle and bone while minimizing activity in other tissues makes it a valuable tool for investigating tissue-specific androgen receptor modulation and potential therapeutic applications in muscle-wasting conditions.
Third-party analytical testing (COA) for Dragon Pharma RAD 140 10 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.
This product is supplied through the official Dragon Pharma distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Store tablets at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. Keep the sachet sealed until use to maintain product integrity.
Keep out of reach of children. Follow proper handling and disposal practices during research use.
Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.
RAD 140 is used in research to investigate selective androgen receptor modulation, lean muscle growth, strength enhancement, and bone health. It is a potent SARM also known as Testolone.
RAD 140 selectively binds to androgen receptors in muscle and bone tissue, promoting anabolic signaling while minimizing activity in other tissues such as the prostate. This tissue selectivity makes it valuable for investigating targeted androgen receptor modulation.
RAD 140 has an estimated half-life of approximately 20–24 hours, allowing for once-daily oral administration in research settings.
Research dosages vary depending on the experimental design. In preclinical studies, doses have ranged from 0.1 to 1 mg/kg in animal models. Proper dose titration and monitoring are essential.
Third-party laboratory testing for RAD 140 10 mg is currently pending. Batch-specific COA data will be published once analytical testing is completed and verified.
Please log in to write RAD 140 review.
CLASSIFICATION: SELECTIVE ANDROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: MASTORIN
FORM: 100 PILLS x 10 MG
ACTIVE HALF-LIFE: ~ 12 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: N/A
WATER RETENTION: N/A
HIGH BLOOD PRESSURE (HBP): N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE SECTRETAGOGUE
ACTIVE SUBSTANCE: IBUTAMERON
FORM: 100 PILLS x 25 MG
ACTIVE HALF-LIFE: ~ 24 HOURS
DOSAGE: MEN 20-30 MG/DAY
ACNE: RARE
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: SELECTIVE ANDROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: LIGANDROL
FORM: 100 PILLS x 15 MG
ACTIVE HALF-LIFE: 24–36 HOURS
DOSAGE: 5–10 MG/DAY
ACNE: LOW
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: SELECTIVE ANDROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: OSTARINE
FORM: 100 PILLS x 25 MG
ACTIVE HALF-LIFE: ~ 24 HOURS
DOSAGE: MEN - 20-30 MG/DAY
ACNE: RARE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: SELECTIVE ANDROGEN RECEPTOR MODULATOR
ACTIVE SUBSTANCE: YK 11
FORM: 100 PILLS x 10 MG
ACTIVE HALF-LIFE: 6-10 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: POSSIBLE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: PPAR RECEPTOR AGONIST
ACTIVE SUBSTANCE: CARDARINE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: ~16–24 HOURS
DOSAGE: 10–20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
Potential effects and adverse reactions vary between individuals.
CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: FLUOXYMESTERONE
FORM: 100 PILLS x 10 MG
ACTIVE HALF-LIFE: 9 HOURS
DOSAGE: MEN 10-40 MG/DAY
ACNE: YES
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): PERHAPS
HEPATOTOXICITY: HIGH
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS